Effect of pleural lavage cytology on the prognosis of patients with non-small cell lung cancer

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1900028704

Enrollment

Unknown

Registered

2019-12-31

Start date

2019-11-01

Completion date

Unknown

Last updated

2020-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Cancer

Interventions

Case series:None

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18-75 years old; 2. Pathologically confirmed non-small cell lung cancer; 3. Feasible surgical treatment in preoperative evaluation; 4. Good condition without serious organ dysfunction.

Exclusion criteria

Exclusion criteria: 1. With malignant pleural effusion before surgery 2. Accepted chemotherapy, radiotherapy, targeted therapy or immunotherapy before surgery 3. Bad condition with serious organ dysfunction 4. Participating in other clinical trials at the same time 5. malignant pleural effusion before surgery 6. distant metastasis before surgery 7. percutaneous lung tumor biopsy before surgery 8. Other conditions that patient is not suitable for the trial after selection

Design outcomes

Primary

Measure	Time frame
DFS;Recurrence rate;Overall survival time;	—

Secondary

Measure	Time frame
Amount of pleural lavage liquid;Temperature of pleural lavage liquid;Pathology of cancer;Distance from the pleura;Pathological staging;Lymph nodes metastasis;	—

Countries

China

Contacts

Public ContactJunhang Zhang

The Seventh Affiliated Hospital of Sun Yat-sen University

2662357712@qq.com+86 13903056256

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026